查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2014904

抽脂手术市场：按类型、方法、应用部位、最终用户和性别划分－2026年至2032年全球市场预测

Liposuction Surgical Procedures Market by Type, Technique, Application Area, End User, Gender - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，抽脂手术市场价值将达到 18.2 亿美元，到 2026 年将成长到 19.2 亿美元，到 2032 年将达到 28.7 亿美元，复合年增长率为 6.73%。

主要市场统计数据
基准年 2025 18.2亿美元
预计年份：2026年 19.2亿美元
预测年份 2032 28.7亿美元
复合年增长率 (%) 6.73%

对现代抽脂术实践进行全面概述，阐明方法、临床因素和相关人员的决策因素。

抽脂手术正在迅速发展，将精湛的技术与科技创新相结合，以满足不断变化的临床需求和患者偏好。本分析概述了医疗设备创新如何重塑市场准入途径、手术技术如何差异化以及医疗服务模式如何演变，从而为决策者提供策略背景。本报告并未将抽脂手术视为单一类别，而是根据技术、临床应用领域和最终用户对市场进行细分，并指出哪些领域的渐进式改进和新进者最有可能影响医疗保健格局。

抽脂医学的策略转型是由医疗设备的创新、医疗服务地点的转变以及对病患​​疗效和復健的日益重视所驱动的。

抽脂市场格局正经历着变革性的转变，其驱动因素包括能量辅助设备的科技进步、门诊和诊所手术的广泛接受，以及患者对恢復时间和治疗效果日益增长的关注。能量辅助技术的成熟使得组织标靶化和止血更加精准，影响了外科医师的选择，并拓展了微创手术的适应症。同时，人体工学、设备便携性和一次性组件设计的进步，提高了手术效率，并推动了手术模式从以医院为中心的模式向门诊手术中心和专业美容诊所的转变。

美国关税调整对抽脂设备供应链、采购方式和临床连续性的实际影响。

关税和贸易措施的实施将对全球医疗设备供应链产生重大影响，进而可能影响筹资策略、供应商选择和价格趋势。对于在美国运营的製造商和经销商，关税调整通常会促使他们重新评估零件采购、契约製造协议和库存布局，以降低成本波动风险。在实践中，受影响的企业通常会透过供应商多元化、加快本地化进程或重新设计物料材料清单(BOM) 来应对，尽可能用国内采购的零件替代受关税影响的零件。

一种严格的细分方法，将医疗设备模式、临床技术、解剖应用部位、医疗环境和患者人口统计特征联繫起来，以指导实践见解。

一套精细的细分框架揭示了每种模式、技术、解剖目标区域、临床环境和患者群体在医疗设备的不同趋势。依类型划分，市场可分为雷射辅助、能量辅助、射频辅助、抽吸辅助及超音波辅助系统。雷射辅助系统进一步细分为Slimlipo和Smartlipo两种变体，而超音波辅助系统则以Vaser技术为参考进行分析。这种结构阐明了能量分布、精确度和温度控管如何影响临床应用。基于手术方式，该分析比较了超湿式、传统式、肿胀麻醉式和湿式抽脂术，揭示了止血、麻醉剂和术中流体动力学之间的权衡。基于应用部位，该分析区分了腹部、手臂、下颚颈部、臀部和大腿手术的临床实践，重点突出了解剖结构挑战、塑形目标和併发症风险方面的差异。基于终端用户，我们分析了门诊手术中心、美容诊所和医院的设备部署模式，揭示了设施限制、认证流程和报销模式如何影响设备的采购和使用。透过按性别划分女性和男性患者群体，我们有助于解释美感偏好、组织特征和季节性需求的差异。结合这些细分观点，相关人员可以确定在哪些方面投资于培训、设备功能或定向行销能够带来最大的临床和商业性回报。

影响抽脂手术受欢迎程度的区域趋势受到法规差异、文化偏好和医疗基础设施的影响。

区域趋势凸显了管理体制、报销环境和文化偏好如何影响临床应用和商业策略。在美洲，主要临床中心的紧密网络、大规模的美容医学专业人员群体以及对微创解决方案的重视（优先考虑快速恢復和美观改善），都影响了创新轨迹。跨境供应链关係和区域製造地也影响设备的定位和支援系统。

针对抽脂领域的公司，我们制定了一项竞争策略，将设备创新、临床教育和综合服务模式结合，以促进产品的普及和信任。

抽脂领域主要企业正透过产品创新、临床医生培训计画以及优先考虑安全性和治疗效果的综合服务模式来脱颖而出。主要医疗设备製造商正投资于迭代式设计改进，以增强热控制、缩短手术时间并简化使用者介面，从而降低医疗专业人员从传统技术过渡到新技术的门槛。同时，提供结合术前评估、手术实施和术后监测的综合护理服务的机构，正在提高患者满意度并促进重复转诊模式。

针对每种医疗保健环境，提出切实可行的策略建议，以提高医疗保健机构的临床可靠性、供应链韧性和商业化水准。

产业领导者应优先进行一系列合作倡议，以提升临床可信度、确保供应链韧性并扩大其在各类医疗机构中的应用。首先，应投资于全面的临床证据项目，包括多中心註册研究和病患报告结局指标（PRO），以支持其在美观性和安全性方面取得的显着改善。这一实证基础将为临床医生培训和与保险公司的咨询提供支援。其次，应设计可扩展的教育项目，将实践操作与数位化学习模组结合，以加速从业人员能力的提升，同时降低手术差异性和併发症发生率。

高度透明的混合方法研究途径，结合临床文献、对医疗保健专业人员的访谈和情境分析，产生了实用的见解。

本调查方法结合了系统性的二手文献综述、结构化的初次访谈和情境分析，以确保研究结果具有实证依据和实际应用价值。二手资讯包括同行评审的临床文献、监管文件和专业学会的程序指南，这些资讯用于建立基准临床参数和安全考虑。为了补充这些信息，我们还对执业外科医生、临床教育工作者、采购负责人和器械工程师进行了初次访谈，以收集有关推广障碍、培训需求和供应链限制的真实案例。

一项决定性的策略整合，突显了创新、临床证据和营运可靠性的交汇点，指导未来的部署。

总之，现代抽脂术的发展趋势体现在向能量辅助和微创技术的转变、向门诊和诊所手术模式的推进，以及市场对可验证的临床价值和可靠供应链的重视。投资于严谨的临床证据、可扩展的培训体系和多元化供应链的相关人员，将能够获得更可预测的推广效果，并与医疗专业人员建立更牢固的关係。同样，那些透过上市后监测和治疗效果评估来支持临床医生，并根据特定解剖结构和手术需求量身定制产品功能的公司，将更有利于确保长期的信任。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：抽脂手术市场：依类型划分

  • 雷射辅助
    • 纤体塑形
    • 智慧型锂电池
  • 动力辅助型
  • 高频辅助型
  • 吸力辅助型
  • 超音波辅助
    • Vaser

第九章 抽脂手术市场：依技术划分

  • 超湿润
  • 传统方法
  • 膨胀法
  • 湿的

第十章：抽脂手术市场：依应用领域划分

  • 腹部
  • 手臂
  • 下颚和颈部
  • 臀部
  • 大腿

第十一章：抽脂手术市场：依最终用户划分

  • 门诊手术中心
  • 美容诊所
  • 医院

第十二章 抽脂手术市场：性别

  • 女士
  • 男性

第十三章 抽脂手术市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：抽脂手术市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：抽脂手术市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 美国抽脂手术市场

第十七章 中国抽脂手术市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Alma Lasers Ltd.
  • Candela Corporation
  • Cutera, Inc.
  • Fotona doo
  • Hologic, Inc.
  • InMode Ltd.
  • Johnson & Johnson
  • Lumenis Ltd.
  • Sciton, Inc.
  • Stryker Corporation
Product Code: MRR-43470FC608C4

The Liposuction Surgical Procedures Market was valued at USD 1.82 billion in 2025 and is projected to grow to USD 1.92 billion in 2026, with a CAGR of 6.73%, reaching USD 2.87 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.82 billion
Estimated Year [2026] USD 1.92 billion
Forecast Year [2032] USD 2.87 billion
CAGR (%) 6.73%

Comprehensive orientation to contemporary liposuction surgical practice that clarifies modalities, clinical drivers, and decision levers for stakeholders

Liposuction procedures continue to evolve rapidly, blending refinements in technique with technological innovation to meet changing clinical expectations and patient preferences. This analysis introduces the strategic context for decision-makers by outlining the interplay of device innovation, procedural technique differentiation, and shifting care delivery models that are reshaping adoption pathways. Rather than treating liposuction as a monolithic category, the report disaggregates the landscape by modality, clinical application area, and end user to reveal where incremental improvements and new entrants are most likely to influence care patterns.

The introduction establishes a clear framework for understanding how procedural efficacy, safety profiles, practitioner training, and consumer demand converge. It emphasizes the importance of longitudinal clinical evidence, the role of minimally invasive adjuncts, and the increasing emphasis on patient experience and aesthetic outcomes. The purpose is to equip clinical leaders, device manufacturers, and strategic investors with a concise orientation that clarifies terminology, distinguishes emerging approaches from legacy practices, and sets expectations for the sections that follow.

Strategic transformation of liposuction care driven by device innovation, site-of-care migration, and an amplified focus on patient outcomes and recovery

The liposuction landscape is undergoing transformative shifts driven by converging forces: technological refinement of energy-assisted devices, broader acceptance of ambulatory and office-based procedures, and heightened patient emphasis on recovery time and visible outcomes. Energy-assisted techniques have matured to provide more precise tissue targeting and hemostasis, thereby influencing surgeon preference and expanding the candidate pool for less invasive interventions. Simultaneously, advances in ergonomics, device portability, and disposable component design are enabling greater procedural throughput and facilitating transitions from hospital-centric models to ambulatory surgical centers and specialized cosmetic clinics.

Regulatory dynamics and evolving clinical guidelines are also reshaping product development priorities, prompting manufacturers to prioritize safety features, standardized training pathways, and real-world evidence generation. Payor perspectives are evolving as well, with clinical utility increasingly scrutinized through the lens of patient-reported outcomes and complication avoidance. As a result, market participation is being redefined by those who can demonstrate differentiating clinical benefits, integrate post-procedural care pathways, and support adoption through structured education and outcome tracking. These shifts create opportunity windows for companies that align product innovation with streamlined care delivery and robust clinician support.

Practical implications of United States tariff adjustments on liposuction device supply chains, procurement behavior, and clinical continuity

The imposition of tariffs and trade measures can create material shocks to global medical device supply chains, influencing procurement strategies, sourcing decisions, and pricing dynamics. For manufacturers and distributors operating within the United States, tariff adjustments often trigger reassessments of component sourcing, contract manufacturing agreements, and inventory positioning to mitigate cost volatility. In practice, affected organizations respond by diversifying supplier bases, accelerating localization efforts, or redesigning product bill-of-materials to substitute tariff-exposed components with domestically sourced alternatives when feasible.

Clinicians and facilities indirectly experience the impact of tariffs through adjustments in device pricing, service contracts, and the availability of consumables. Procurement teams may prioritize vendors with resilient supply chains and transparent cost-management practices. Over time, sustained tariff pressure can incentivize vertically integrated strategies or strategic partnerships that internalize higher-value manufacturing activities to preserve margin and ensure continuity of supply. Equally important, manufacturers that proactively communicate supply chain contingencies and provide clinical support for product transitions tend to retain practitioner trust and minimize disruptions to patient care delivery.

Rigorous segmentation approach linking device modality, clinical technique, anatomical application, care setting, and patient demographics to actionable insights

A nuanced segmentation framework reveals differentiated adoption dynamics across device modality, technique, anatomical target areas, care setting, and patient demographics. Based on Type the market is analyzed across Laser Assisted, Power Assisted, Radio Frequency Assisted, Suction Assisted, and Ultrasound Assisted systems, with Laser Assisted further categorized into Slimlipo and Smartlipo variants and Ultrasound Assisted examined with reference to Vaser technology; this structure clarifies how energy profile, precision, and thermal management drive clinical use cases. Based on Technique liposuction procedures are contrasted across Superwet, Traditional, Tumescent, and Wet approaches to illuminate trade-offs between hemostasis, anesthetic dosing, and intraoperative fluid dynamics. Based on Application Area the analysis differentiates clinical practice across abdomen, arms, chin neck, hips, and thigh procedures to highlight anatomical challenges, contouring goals, and complication risk differentials. Based on End User adoption patterns are dissected across ambulatory surgical centers, cosmetic clinics, and hospitals to show how facility constraints, credentialing processes, and reimbursement models influence procurement and utilization. Based on Gender consideration of female and male patient cohorts helps explain variation in aesthetic priorities, tissue characteristics, and demand seasonality. Together these segmentation lenses enable stakeholders to identify where investments in training, device feature sets, or targeted marketing will deliver the greatest clinical and commercial returns.

Regional dynamics shaping adoption of liposuction procedures driven by regulatory variation, cultural preferences, and differences in care infrastructure

Regional dynamics underscore how regulatory regimes, reimbursement environments, and cultural preferences shape clinical adoption and commercial strategy. In the Americas innovation trajectories are influenced by a dense network of leading clinical centers, a large base of cosmetic practitioners, and an emphasis on minimally invasive solutions that prioritize quick recovery and aesthetic refinement. Cross-border supply chain relationships and regional manufacturing footprints also affect how devices are positioned and supported.

In Europe, Middle East & Africa regulatory harmonization efforts coexist with diverse national health systems, leading manufacturers to adopt flexible market entry and clinical validation pathways that accommodate localized credentialing and training requirements. Cultural preferences for aesthetic norms and the distribution of specialist practitioners influence the mix of procedural application areas and the configuration of support services. In the Asia-Pacific region rapid urbanization, expanding middle-class demand for aesthetic procedures, and growing investment in ambulatory care infrastructure are driving increased procedural volumes and interest in portable, cost-efficient technologies. The diversity of reimbursement practices and clinician training ecosystems across these regions requires tailored commercialization plans that reflect local priorities and operational realities.

Competitive company strategies in liposuction that combine device innovation, clinical education, and integrated service models to drive adoption and trust

Key companies in the liposuction ecosystem are differentiating through product innovation, clinician education programs, and integrated service models that emphasize safety and outcomes. Leading device manufacturers are investing in iterative design improvements that enhance thermal control, reduce procedure time, and simplify user interfaces to lower the barrier to adoption among practitioners transitioning from traditional techniques. Concurrently, providers that offer bundled care services-combining preoperative assessment, procedural execution, and postoperative monitoring-are demonstrating improved patient satisfaction and facilitating repeat referral patterns.

Partnerships between device firms and surgical training organizations are becoming a central strategy to accelerate adoption; manufacturers that offer structured proctoring, simulation-based training, and long-term outcome tracking build clinical confidence more effectively than those relying on transactional sales models. Moreover, companies that align product roadmaps with emerging reimbursement criteria and produce robust real-world evidence to support safety and efficacy claims are better positioned to sustain clinician and payor support. The competitive landscape favors agile firms that integrate clinical insights, responsive service models, and pragmatic supply chain strategies to support consistent product availability and practitioner trust.

Actionable strategic recommendations to fortify clinical credibility, supply chain resilience, and tailored commercialization across care settings

Industry leaders should prioritize a coordinated set of actions that strengthen clinical credibility, secure supply chain resilience, and expand adoption across diverse care settings. First, invest in comprehensive clinical evidence programs that include multi-center registries and patient-reported outcome measures to substantiate claims of improved aesthetic and safety profiles; this empirical foundation supports clinician training efforts and payor discussions. Next, design scalable education pathways that pair hands-on proctoring with digital learning modules to accelerate operator competency while reducing procedural variability and complication rates.

Operationally, diversify supplier relationships and consider nearshoring critical components to mitigate exposure to tariff-related cost disruption. Simultaneously, adopt modular device designs that facilitate component substitution and servicing to preserve uptime in ambulatory contexts. On the commercialization front, tailor value propositions to facility type by emphasizing throughput and cost-per-case for ambulatory surgical centers, streamlined disposable logistics for cosmetic clinics, and compliance and safety features for hospitals. Finally, pursue partnerships with clinical centers of excellence to create reproducible clinical protocols and to serve as demonstration sites for prospective customers. Taken together, these measures create a defensible market position grounded in clinical value and operational reliability.

Transparent mixed-methods research approach integrating clinical literature, practitioner interviews, and scenario analysis to produce actionable insights

The research methodology combines systematic secondary literature review, structured primary interviews, and scenario-based analysis to ensure findings are evidence-based and operationally relevant. Secondary sources included peer-reviewed clinical literature, regulatory filings, and procedural guidance from professional societies to establish baseline clinical parameters and safety considerations. These inputs were complemented by primary interviews with practicing surgeons, clinical educators, procurement specialists, and device engineers to capture real-world insights on adoption barriers, training needs, and supply chain constraints.

Data synthesis employed qualitative coding of interview transcripts to identify recurring themes and to triangulate practitioner-reported experiences with documented clinical outcomes. Scenario analysis was used to explore how alternative policy developments, reimbursement shifts, or technological breakthroughs could plausibly alter adoption pathways. Where applicable, the methodology prioritized transparency in assumptions and clear documentation of inclusion criteria for clinical studies and interview selection to enable readers to assess the robustness of the conclusions and to adapt the findings to their organizational context.

Conclusive strategic synthesis highlighting the intersection of innovation, clinical evidence, and operational reliability that will guide future adoption

In conclusion, the contemporary liposuction landscape is defined by a shift toward energy-assisted and minimally invasive modalities, a migration of procedures to ambulatory and office-based settings, and a marketplace that rewards demonstrable clinical value and reliable supply chains. Stakeholders who invest in rigorous clinical evidence, scalable training infrastructures, and supply chain diversification stand to achieve more predictable adoption outcomes and stronger practitioner relationships. Equally, companies that align product features with specific anatomical and procedural needs, while supporting clinicians through post-market surveillance and outcome measurement, are better positioned to secure long-term credibility.

Decision-makers should view the current environment as an opportunity to re-evaluate product portfolios, prioritize investments that reduce procedural variability, and forge partnerships that accelerate clinician confidence. By focusing on patient safety, measurable outcomes, and operational reliability, manufacturers and providers can collectively elevate standards of care while capturing sustainable commercial benefit. The insights offered in this report are intended to inform those strategic choices and to provide a practical roadmap for translating clinical innovation into routine, high-quality practice.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Liposuction Surgical Procedures Market, by Type

  • 8.1. Laser Assisted
    • 8.1.1. Slimlipo
    • 8.1.2. Smartlipo
  • 8.2. Power Assisted
  • 8.3. Radio Frequency Assisted
  • 8.4. Suction Assisted
  • 8.5. Ultrasound Assisted
    • 8.5.1. Vaser

9. Liposuction Surgical Procedures Market, by Technique

  • 9.1. Superwet
  • 9.2. Traditional
  • 9.3. Tumescent
  • 9.4. Wet

10. Liposuction Surgical Procedures Market, by Application Area

  • 10.1. Abdomen
  • 10.2. Arms
  • 10.3. Chin Neck
  • 10.4. Hips
  • 10.5. Thigh

11. Liposuction Surgical Procedures Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Cosmetic Clinics
  • 11.3. Hospitals

12. Liposuction Surgical Procedures Market, by Gender

  • 12.1. Female
  • 12.2. Male

13. Liposuction Surgical Procedures Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Liposuction Surgical Procedures Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Liposuction Surgical Procedures Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Liposuction Surgical Procedures Market

17. China Liposuction Surgical Procedures Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Alma Lasers Ltd.
  • 18.6. Candela Corporation
  • 18.7. Cutera, Inc.
  • 18.8. Fotona d.o.o.
  • 18.9. Hologic, Inc.
  • 18.10. InMode Ltd.
  • 18.11. Johnson & Johnson
  • 18.12. Lumenis Ltd.
  • 18.13. Sciton, Inc.
  • 18.14. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SLIMLIPO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SLIMLIPO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SLIMLIPO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SMARTLIPO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SMARTLIPO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SMARTLIPO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY POWER ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY POWER ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY POWER ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY RADIO FREQUENCY ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY RADIO FREQUENCY ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY RADIO FREQUENCY ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SUCTION ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SUCTION ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SUCTION ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY VASER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY VASER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY VASER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SUPERWET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SUPERWET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SUPERWET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TRADITIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TRADITIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TRADITIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TUMESCENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TUMESCENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TUMESCENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY WET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY WET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY WET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ABDOMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ABDOMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ABDOMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY CHIN NECK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY CHIN NECK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY CHIN NECK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY HIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY HIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY HIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY THIGH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY THIGH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY THIGH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COSMETIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COSMETIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COSMETIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY FEMALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY FEMALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY MALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY MALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY MALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 149. GCC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GCC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 152. GCC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 153. GCC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 154. GCC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 155. GCC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. GCC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 173. G7 LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. G7 LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. G7 LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 176. G7 LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 177. G7 LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 178. G7 LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 179. G7 LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. G7 LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 181. NATO LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. NATO LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. NATO LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 184. NATO LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 185. NATO LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 186. NATO LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 187. NATO LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. NATO LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)